A review of ramelteon in the treatment of sleep disorders
A review of ramelteon in the treatment of sleep disorders
About this item
Full title
Author / Creator
Publisher
New Zealand: Taylor & Francis Ltd
Journal title
Language
English
Formats
Publication information
Publisher
New Zealand: Taylor & Francis Ltd
Subjects
More information
Scope and Contents
Contents
Ramelteon is a selective melatonin receptor (MT(1) and MT(2)) agonist that has been approved by the US Food and Drug Administration for the treatment of insomnia characterized by difficulty with sleep onset. It is the only approved sleep-promoting medication that does not have a direct sedating effect, but rather enhances sleep through effects on s...
Alternative Titles
Full title
A review of ramelteon in the treatment of sleep disorders
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_9fe37eaa595747798f535232e235e187
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9fe37eaa595747798f535232e235e187
Other Identifiers
ISSN
1176-6328
E-ISSN
1176-6328,1178-2021
DOI
10.2147/ndt.s483
